OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex biologics. Enhancing these processes involves fine-tuning various variables, including cell line development, media ingredients, and bioreactor conditions. A key goal is to maximize antibody titer while lowering production costs a